Idexx Laboratories (IDXX) Short term Debt (2009 - 2026)

Idexx Laboratories (IDXX) has reported Short term Debt for 18 consecutive years, with $530.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short term Debt rose 210.07% year-over-year to $530.0 million; the TTM figure through Mar 2026 stood at $530.0 million (up 210.07% YoY), while the FY2025 annual figure was $75.0 million, down 70.0% from the prior year.
• Short term Debt came in at $530.0 million for Q1 2026 at Idexx Laboratories, up from $75.0 million in the prior quarter.
• The five-year high for Short term Debt was $633.0 million in Q3 2022, with the low at $75.0 million in Q4 2025.
• Average Short term Debt over 5 years is $299.9 million, with a median of $250.0 million recorded in 2022.
• Across the five-year window, Short term Debt soared 744.11% in 2022 and slumped 76.3% in 2023, its largest moves.
• Year by year, Short term Debt stood at $250.0 million in 2022, then tumbled by 70.0% to $75.0 million in 2023, then surged by 233.35% to $250.0 million in 2024, then slumped by 70.0% to $75.0 million in 2025, then surged by 606.71% to $530.0 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $530.0 million, $75.0 million, and $455.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.